Ascendis Pharma A/S (ASND) vs Genmab A/S Sponsored ADR (GMAB)

Ascendis Pharma A/S and Genmab A/S Sponsored ADR are both Biotechnology companies. Genmab A/S Sponsored ADR is the larger, with a market value of $20.8B against $15.7B — 1.3× the size. Ascendis Pharma A/S trades at the lower P/E: 16.3× against 27.8×. Ascendis Pharma A/S grew revenue faster over the last twelve months: 126.0% against 22.3%. Ascendis Pharma A/S has the higher net margin (71.2% vs 19.1%) and the higher return on invested capital (15.1% vs 6.99%). Across the 21 metrics below, Ascendis Pharma A/S leads on 14 and Genmab A/S Sponsored ADR on 7.